Biomarin Pharmaceutical Stock (NASDAQ: BMRN)
|Day Range85.77 - 88.08||52 Wk Range70.73 - 97.76||Open / Close87.18 / -||Float / Outstanding184.6M / 185.5M|
|Vol / Avg.631.9K / 971.7K||Mkt Cap16.1B||P/E309.64||50d Avg. Price89.7|
|Div / Yield-||Payout Ratio-||Total Float184.6M||EPS0.15|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Biomarin Pharmaceutical (NASDAQ: BMRN) through any online brokerage.
The latest price target for Biomarin Pharmaceutical (NASDAQ: BMRN) was reported by Piper Sandler on Tuesday, August 9, 2022. The analyst firm set a price target for 128.00 expecting BMRN to rise to within 12 months (a possible 47.04% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $87.05 last updated Today at October 4, 2022, 6:47 PM UTC.
There are no upcoming dividends for Biomarin Pharmaceutical.
Biomarin Pharmaceutical’s Q3 earnings are confirmed for Wednesday, October 26, 2022.
There is no upcoming split for Biomarin Pharmaceutical.
Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.